Answers are grounded in this paper and cite their sources.
Wei Zhanga, Li-Jin Fenga*, Fei Tengb, Yan-Hong Lib, Xi Zhangb & Yu-Ge Ranb* a Department of Pathology, Shanghai Tenth People`s Hospital, Tongji University, School of Medicine, Shanghai, Chinab Department of Radiotherapy, Affiliated Hospital of Hebei University, Baoding, ChinaCONTACT Yu-Ge Ran ranyugemd@sohu.com Department of Radiation Oncology, Affiliated Hospital of Hebei University, 212 East Yuhua Road, Baoding, Hebei 071000, P. R. China* These authors contributed equally to this work.ABSTRACTObjective: We performed a meta-analysis to quantify the overall incidence and risk of proteinuria associated with five newly approved VEGFR-TKIs (regorafenib, vandetanib, cabozantinib, lenvatinib, axitinib) in cancer patients.Methods: Pubmed, Embase, ASCO abstracts, and ESMO abstracts were searched to identify relevant studies. Overall incidence rates, relative risk (RR), and 95% confidence intervals (CI) were estimated using random or fixed effects models according to the heterogeneity of included studies.Results: A total of 9,446 patients from 20 RCTs were included for the meta-analysis. The use of newly approved VEGFR-TKIs was associated with an increased risk of all-grade (RR 2.35, 95% CI 1.69–3.27, P < 0.001) and high-grade (RR 3.70, 95% CI 2.09–6.54, P < 0.001) proteinuria. On subgroup analysis, lenvatinib, axitinib, and vandetanib significantly increased the risk of all-grade proteinuria, and lenvatinib was associated with an increased risk of high-grade proteinuria. In addition, the risk of developing high-grade proteinuria events was significant for patients with hepatocellular carcinoma (HCC) and renal cell carcinoma (RCC), but not for patients with colorectal cancer (CRC) and thyroid cancer (TC).Conclusion: Treatment with newly approved VEGFR-TKIs significantly increases the risk of developing proteinuria events in cancer patients, especially for patients treated with lenvatinib.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: